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1. Introduction 
In recent years an increasing number of reports 
have dealt with the production and the specificity of 
antisera gainst prostaglandins (Pg) [1-9]. The anti- 
sera exhibited specificity for both the cyclopentane 
ring structure and the degree of unsaturation of the 
side chains. However, while the specificity of antisera 
against prostaglandins of the F series was considerable 
[2, 3, 6-9] and PgFla and PgF2~ could be differen- 
tiated by radioimmunoassay [ 10], antisera gainst 
prostaglandins of the A and E series often showed 
strong cross-reactions with prostaglandins A, B and E 
[1--4, 11]. In fact, several investigators [2, 3] have 
suggested that it would be impossible to obtain 
sufficiently specific antibodies against PgE and PgA. 
Only recently the production of more specific anti- 
sera against PgE 1 [11, 12] and PgA 1 [5] has been 
described. However, there is also much interest in the 
specific measurement of the dienoic prostaglandins 
PgE 2 PgA 2, since they seem to be widely distributed 
in biological material. Recently Zusman et al. [4] 
attempted toproduce specific antibodies to PgE2, but 
obtained antibodies directed mainly against PgA 2 
with considerable cross-reactions with PgA 1 (53%), 
PgE 2 (26%) and PgE 1 (19%). This paper describes the 
specificity of antisera gainst PgA 2 and PgE 2. 
2. Materials and methods 
Prostaglandins A1, A 2, El, E2, Fla and F2a 
(Upjohn Co.) were a generous gift of Dr. S. Spector, 
Nutley, N.J. PgE1-5, [3H] 6 (specific activity 68.5 Ci/ 
mmole) and PgA1-5, [3H]6 (specific activity 132 Ci/ 
mmole) were bought from New England Nuclear Co. 
[3H]PgBI, PgB 1 and PgB 2 were prepared according to 
the method of Zusman [13] from [3H]PgE1, PgE 1 and 
PgE 2 respectively. The antigens for immunization of the 
rabbits were synthetized by the method of Goodfriend 
et al. [14], using 7.5 mg bovine serum albumin (BSA), 
4 mg 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
(CDI) and 4 mg PgE 2 or PgA 2 respectively. After in- 
cubation at room temperature overnight the prepara- 
tion was dialyzed exhaustively against many changes 
of distilled water. 250/ag of antigen in 0.5 ml saline 
were emulsified with an equal volume of complete 
Freund's adjuvant and injected into the toe pads of 
rabbits (3 per group), followed by 100/zg one and 
three weeks after the starting dose. The rabbits were 
bled 10-14 days after booster injections and the sera 
checked for the presence of antibodies using agar 
diffusion plates and microcomplement fixation [ 15]. 
Radioimmunoassay was performed as described 
previously [ 16], using charcoal for separation of the 
free and antibody-bound fractions. 
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All rabbits immunized with the prostaglandin 
immunogens ot only produced antibodies against he 
backbone molecule BSA as shown by agar diffusion 
plates and microc'omplement f'Lxation, but also against 
the prostaglandins. The presence of the latter anti- 
bodies was shown by microcomplement fixation and 
the specific binding of tritiated prostaglandins by sera 
from the immunized animals as compared to the bind- 
ing by a pool of normal rabbit sera or by preimmuniza- 
tion sera from the same animals. 
Fig. 1 shows titration curves of 2 rabbit sera, 
obtained about 2 months after the first injection of 
PgE2-CDI-BSA (left side) or PgA2-CDI-BSA (right 
side), using three different labelled prostaglandins a
antigens. For these experiments equal specific activities 
of the labelled compounds were used and the results 
were corrected for the minimal binding shown by 
normal rabbit sera. While the titration curves for 
[3H]PgA1 and [3H]PgB1 are similar for both sera, 
only the anti-PgE 2 antiserum binds [3H]PgE 1 . Fig. 2 
shows, that this binding of [3H]PgE 1 is rather specific. 
Of all the prostaglandins checked PgE 2 was most 
effective in displacing [3H]PgE 1 from the antibody 
(50% displacement with 1.6 moles), followed by 
PgE 1 (50% displacement with 2.9 pmoles) and PgA 2 
(50% displacement with 16.5 pmoles). The effect of 
PgA1, PgB1, PgB2, PgFla and PgF2a in the dose range 
used was comparably small. 
However, using the same antiserum and [3H]PgA 1 
or [3H]PgB 1 as the labelled antigen, the specificity of 
the antiserum seems changed (table 1). [3H]PgA1 is 
displaced most effectively by PgA 2 and [3H]PgB 1 by 
PgB 2 . PgE 2 was almost ineffective as an inhibitor in 
both reactions. 
Fig. 3 shows the specificity of the reaction between 
[3H]PgA 1 and the serum obtained from a rabbit which 
had been immunized with PgA2-CDI-BSA. While the 
PgE and PgF compounds in the dose range used do 
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Fig. 1. Binding of [3H]PgAI, [3H]PgB1 and [3H]PgEt by serum obtained from rabbits immunized with PgE2-CDI-BSA (left 
side) or PgA2-CDI-BSA (right side). 2000 cpm of the labelled compounds were used at equal specific activity (68.5 Ci/mmole) 
and the curves corrected for the binding by normal rabbit serum. 
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Fig. 2. Inhibition of [ 3H ] PgE 1 -anti-PgE2 binding by various prostaglandins. Final antiserum dilution employed was 1:1600. 
not inhibit the reaction, both PgA and PgB compounds 
effectively displace [3H]PgA 1 from the antibody, the 
dienoic compounds PgA 2 and PgB 2 (50% displacement 
with 1.55 pmoles and 1.7 pmoles respectively) being 
more effective by a factor of almost 3 than PgA 1 and 
PgB 1 (50% displacement with 4.0 pmoles and 4 .7  
pmoles respectively). 
4. Discussion 
Our results show, that the antisera obtained after 
immunization of rabbits with PgA2-CDI-BSA or 
PgF2-CDI-BSA are specific not only for the cyclo- 
pentane ring structure, but also for the degree of un- 
saturation of the side chains. The homologous PgE 2 
Table 1 
Specificities of anti-PgE2 antiserum depending on the labelled antigen used. Final antiserum dilutions were 1:4000 for [ aH]PgA1 
binding, 1:10 000 for [aH]PgBI binding and 1:1600 for [3H]PgEI binding. 
Inhibitor 50% displacement of
[3H]PgA1 [aHIPgBt [3H]PgEI 
PgA2 0.8 pmoles > 30 pmoles** 16.5 pmoles 
PgB2 3.6 pmoles 2.4 pmoles > 30 pmolest 
PgE2 > 30 pmoles* > 30 pmoles*** 1.6 pmoles 
* 36% Inhibition with 30 pmoles. 
** 43% Inhibition with 30 pmoles. 
*** 8% Inhibition with 30 pmoles. 
t 26% Inhibition with 30 pmoles. 
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Fig. 3 lnht l~tn-m of  [~HIPgAn Ant~-Pg.~,2 b ind ing b~, var ious  pros~ms.  F znal antz. _rum d i luUon ernptoytd  was 1 3OOO 
brad better to the ant]-PgE 2 antv~rum than PgE n . and 
PgA 2 bu,ds better to the anti-PgA, antiserum than 
PKA 1 . The vmw. that the 5.b double bond is recognized 
by the antibodw:s is supported b~ the fact. that cross- 
reactions with other dg'noic prostaglandms are stronger 
than wRh the correscondmg mono-unsaturated corn- 
pomps.  So PgA 2 is • better inhibn!or th,,n Pg,A 1 m zhe 
PIOE Wstem (fig. 2) an,d PgB 2 is a better inl~bttor than 
PglB 1 m the PgA ~,m (f'm3. 3 p. Probably the specifi- 
city of our PgA 2- and Pl0E2-radiotmmur oasaay$ could 
be even m c ~  by tmng radtoactlvely labelled ~2 
and PI~2 antigens m~ead of the heteroiogous [3H] -  
v~t md ['MIPzA~- 
et ,,I. [! 7] have u:lentzfmd PgE 2 in ttsm~ 
culture medium, by red~ Pl~ w'lth borohydrhde 
am/amaly'zml the renaltmS PgF m the .  PsF an-anti- 
Obviousl-, immumzat~on with ~ 2 ~ntrgen has led 
to the formatnon of ant]-PgA 2 and antl-PgB 2 antib~tms 
and Lmmun~zatjon with PI~2 antigen to the formatzon 
of anti-PgE,, antl-PgB 2 antibodies, the different anti- 
body populations having different tsters and specifiO- 
ties. The occurrence of anti-PgB antibodies a,-zer 
unmumzatlon with PgA antigens and of an tl-PgA and 
;m.ti-PgB antibodies after imm~za i ion  wlth PgE 
amtigens i  zn accordance with the results of other 
laboratories, [ I -4 ] and has been explained by the m- 
stability of PgE to chemical couphng ~eacziov, s and 
the action of prostaglandm dehydra~ [i 8] ~n~ 
mers [ 19, ~N:)]. However, Raz and Stylos [ 101 and Jaffe 
eta!. [l "l have obtained ~~c anti-PgE i antibodies 
and our results show. that it is also potable to obtain 
speOfic antz-PgE 2 antibodies. The presence of anti- 
1Pl~2. and ~ : . -mm-P~t  a systems. The ~nu]tameom Pl~ and ant i -P~ anribodm in the same serum, bind. 
,me of oar mtisera apmst  PgA 2 and P I l l  [10, 12] m s P~ and PIgB better than the ant i -P~ antibodies 
raN/Sh i l l  [5] amtimra dhould provide a a~nnp4e do. might contribute to tim ~fk i ty  of the PI~ amy.  
m~m to dff1~-rmtmte between PIOE ~ and Pl~2 or 
~ ~d tax2 rmMctm~. 
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